BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2476482)

  • 1. Specific neonatal induction of functional tolerance to allogeneic Mls determinants occurs intrathymically and the tolerant state is Mls haplotype-specific.
    Macphail S; Stutman O
    J Immunol; 1989 Sep; 143(6):1795-800. PubMed ID: 2476482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific neonatally induced tolerance to Mls locus determinants.
    Macphail S; Ishizaka ST; Bykowsky MJ; Lattime EC; Stutman O
    J Immunol; 1985 Nov; 135(5):2967-74. PubMed ID: 2413106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal tolerance induction in the thymus to MHC-class-II-associated antigens. V. Thymus medulla and the site for deletional signaling achievement in Mls tolerance.
    Hosono M; Kurozumi M; Ideyama S; Katsura Y
    Thymus; 1992 Aug; 20(1):31-45. PubMed ID: 1387744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathymic induction of neonatal tolerance to Mls-1a determinant: clonal deletion and clonal anergy by haematolymphoid cells.
    Ideyama S; Hosono M; Imamura S; Tomana M; Katsura Y
    Immunology; 1991 Oct; 74(2):240-5. PubMed ID: 1721041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of neonatal tolerance to the Mls-1a self-super-antigen. Time kinetics and MHC restriction.
    Dannecker G; Mecheri S; Hoffmann MK
    J Immunol; 1991 Nov; 147(9):2833-8. PubMed ID: 1833458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice.
    Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K
    J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
    J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Mls determinants in mice exhibiting the severe combined immunodeficiency (scid) mutation or X-linked immunodeficiency (xid) defect.
    Roberts JL; Abe R; Shores EW; Singer A
    J Immunol; 1992 Sep; 149(5):1577-82. PubMed ID: 1506683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresponsiveness to Mlsa induced in newborn Mlsb mice by maternal preimmunization.
    Matossian-Rogers A; DeGiorgi L
    Immunology; 1991 Feb; 72(2):219-25. PubMed ID: 1826669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus.
    Mazda O; Watanabe Y; Gyotoku J; Katsura Y
    J Exp Med; 1991 Mar; 173(3):539-47. PubMed ID: 1900074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal deletion of self-Mls-reactive thymocytes at the early stage in H-2-compatible but Mls-disparate radiation chimeras.
    Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
    Immunology; 1990 Mar; 69(3):482-6. PubMed ID: 2312170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. IV. Significance of intrathymic chimerism of blood-born Ia+ cells in Mls tolerance.
    Hosono M; Kurozumi M; Inaba M; Ideyama S; Tomana M; Gyotoku J; Katsura Y; Hosokawa T
    Cell Immunol; 1991 Sep; 136(2):373-87. PubMed ID: 1831406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo presentation of Mls-1 antigen by T and B lymphocytes.
    Dannecker G; Mecheri S; Hoffmann MK
    Immunobiology; 1992 Jun; 185(1):20-7. PubMed ID: 1398739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of allogeneic lymphocyte interaction. IV. Dual recognition of B cell-associated Mls locus and I-region determinants by a helper allogeneic effect factor (AEF) generated across a minor H locus disparity.
    Delovitch TL; Sohn U
    J Immunol; 1979 Jul; 123(1):121-7. PubMed ID: 87470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of T cell function by Mtv-7 gene products.
    Hoffmann MK; Dannecker G; Mecheri S
    Semin Immunol; 1992 Oct; 4(5):337-51. PubMed ID: 1336683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
    J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect.
    Ahmed A; Scher I
    J Immunol; 1976 Nov; 117(5 Pt.2):1922-6. PubMed ID: 62796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.